Takeda Pharmaceutical Company Limited
TKPHF
$26.13
-$2.50-8.72%
TKPHF market cap represents
--
of the industry.
Valuation
TKPHF
Low
TKPHF
Industry Average
High
Market Cap
43.51B
--
--
Enterprise Value
75.39B
--
--
Price/Earnings (TTM)
30.57
--
--
Earnings Per Share Growth (TTM)
5.32%
--
--
Price/Earnings To Growth (TTM)
5.75
--
--
Price/Sales (TTM)
1.37
--
--
Price/Book (Q)
0.88
--
--
Enterprise Value/Revenue (TTM)
2.49
--
--
Enterprise Value/EBITDA (TTM)
9.80
--
--
Enterprise Value/EBIT (TTM)
23.23
--
--
Dividends and Shares
TKPHF
Low
TKPHF
Industry Average
High
Shares Outstanding
1.59B
--
--
Dividend Per Share (Most Recent)
98.00
--
--
Dividend Per Share (TTM)
98.00
--
--
Dividend Yield (TTM)
375.05%
--
--
Payout Ratio (TTM)
143.72
--
--
Price History
TKPHF
Low
TKPHF
Industry Average
High
Beta
-0.04
--
--
1-Month Total Return
-16.30%
--
--
3-Month Total Return
-0.15%
--
--
6-Month Total Return
-2.32%
--
--
Year to Date Total Return
-2.32%
--
--
1-Year Total Return
0.99%
--
--
2-Year Total Return
-21.32%
--
--
3-Year Total Return
-8.62%
--
--
5-Year Total Return
-19.33%
--
--
Profitability
TKPHF
Low
TKPHF
Industry Average
High
Operating Margin (TTM)
10.72%
--
--
Profit Margin (TTM)
4.51%
--
--
Management Effectiveness
TKPHF
Low
TKPHF
Industry Average
High
Return on Assets (TTM)
2.06%
--
--
Return on Equity (TTM)
2.88%
--
--
Income Statement
TKPHF
Low
TKPHF
Industry Average
High
Revenue (TTM)
30.24B
--
--
Total Revenue (TTM)
30.24B
--
--
Total Revenue Growth (Q YOY)
-0.34%
--
--
Revenue Per Share (TTM)
19.08
--
--
Gross Profit (TTM)
19.77B
--
--
EBITDA (TTM)
7.69B
--
--
EBIT (TTM)
3.24B
--
--
Net Income (TTM)
1.37B
--
--
Net Income Avl. to Common (TTM)
1.37B
--
--
Earnings Growth (Q YOY)
-78.19%
--
--
EPS Diluted (TTM)
0.85
--
--
EPS Diluted Growth (Q YOY)
-78.45%
--
--
Balance Sheet
TKPHF
Low
TKPHF
Industry Average
High
Cash and Short-Term Inv. (Q)
3.14B
--
--
Cash Per Share (Q)
1.98
--
--
Total Current Assets (Q)
17.52B
--
--
Total Assets (Q)
96.09B
--
--
Total Current Liabilities (Q)
13.34B
--
--
Total Debt (Q)
34.55B
--
--
Total Liabilities (Q)
48.90B
--
--
Total Common Equity (Q)
47.18B
--
--
Total Preferred Equity (Q)
--
--
--
Total Equity (Q)
47.19B
--
--
Current Ratio (Q)
1.313
--
--
Book Value Per Share (Q)
29.77
--
--
Cash Flow
TKPHF
Low
TKPHF
Industry Average
High
Cash from Operations (TTM)
7.38B
--
--
Cash from Investing (TTM)
-2.68B
--
--
Cash from Financing (TTM)
-3.40B
--
--
Net Change in Cash (TTM)
1.34B
--
--
Levered Free Cash Flow (TTM)
4.21B
--
--
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
